Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.

Employees

1,468

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data

Market Closed - NYSE Other stock markets 23:59:52 30/05/2024 +04			5-day change	1st Jan Change
334.79 ^USD	-0.01%		+0.01%	+0.01%

20/05/25	Shockwave Medical Study Confirms Benefit of IVL-First Strategy in Real-World Female Patients with Complex Calcified Lesions in Late-Breaking Data Presentation At EuroPCR 2025	CI
04/03/25	Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-To-Cross Calcified Lesions	CI

Market Cap	12.57B 10.98B 10.13B 9.34B 17.61B 1,210B 18B 121B 47.65B 593B 47.2B 46.16B 2,041B	P/E 2025 *	-	P/E 2026 *	-
Enterprise Value	12.35B 10.79B 9.96B 9.18B 17.3B 1,189B 17.68B 119B 46.81B 582B 46.37B 45.35B 2,005B	EV / Sales 2025 *	-	EV / Sales 2026 *	-
Free-Float	-	Yield 2025 *	-	Yield 2026 *	-

20/05/25	Shockwave Medical Study Confirms Benefit of IVL-First Strategy in Real-World Female Patients with Complex Calcified Lesions in Late-Breaking Data Presentation At EuroPCR 2025	CI
04/03/25	Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-To-Cross Calcified Lesions	CI
04/11/24	Shockwave Medical Unveils First Clinical Outcomes of New IVL Platform in Late-Breaking Presentation at VIVA 2024	CI
16/09/24	Shockwave Medical, Inc. Announces U.S. Launch of the Shockwave E8 Peripheral Ivl Catheter	CI
01/07/24	Momentum Picks Q3 2024: 5 stocks for the summer
03/06/24	Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 1000	CI
03/06/24	Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 400 Health Care	CI
03/06/24	Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P Composite 1500	CI
03/06/24	Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 400	CI
03/06/24	Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P Healthcare Equipment Select Industry Index	CI
03/06/24	Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P Global BMI Index	CI
03/06/24	Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P TMI Index	CI
01/06/24	Shockwave Medical, Inc. Announces Termination of Employment of Douglas Godshall as Chief Executive Officer	CI

09/04/24	CL King Downgrades ShockWave Medical to Neutral From Buy, Cuts Price Target to $335 From $368	MT
08/04/24	Leerink Partners Downgrades ShockWave Medical to Market Perform From Outperform, Cuts Price Target to $335 From $361	MT
08/04/24	Deutsche Bank Downgrades ShockWave Medical to Hold From Buy, Raises Price Target to $335 From $270	MT
08/04/24	Morgan Stanley Downgrades ShockWave Medical to Equal Weight From Overweight, Raises Price Target to $335 From $285	MT
05/04/24	Wolfe Research Downgrades ShockWave Medical to Peer Perform From Outperform	MT

Shockwave Medical Stock

Stocks

SWAV

US82489T1043

Medical Equipment, Supplies & Distribution

Valuation: Shockwave Medical

Latest news : Shockwave Medical

Analysts' recommendations: Shockwave Medical

Press Releases: Shockwave Medical

News in other languages: Shockwave Medical

Quotes and Performance

Course Extremes

Managers and Directors: Shockwave Medical

Latest insider transactions

Medical Equipment

Financials

Company Profile

Income Statement and Estimates

03/06/24	Johnson & Johnson Completes Acquisition of Shockwave Medical	AQ
09/05/24	SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV	BU
07/05/24	Shockwave Medical: Q1 Earnings Snapshot	AQ
07/05/24	Shockwave Medical Reports First Quarter 2024 Financial Results	GL
10/04/24	SWAV Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Shockwave Medical to Johnson & Johnson	AQ

03/07/24	Momentum Picks Q3/ 2024: 5 Aktien für den Sommer
02/07/24	Momentum Picks 3T 2024: 5 valores para el verano
02/07/24	Momentum Picks Q3 2024: vijf aandelen voor de zomer
01/07/24	Momentum Picks Q3 2024: 5 azioni per l'estate
01/07/24	Momentum Picks T3 2024 : 5 actions pour l'été

1 day	-0.01%
1 week	+0.01%
Current month	+0.01%
1 month	+0.01%
3 months	+0.01%
6 months	+0.01%
Current year	+0.01%

Manager	Title	Age	Since
Trinh Phung DFI	Director of Finance/CFO	48	31/05/2024
Isaac Zacharias PSD	President	51	01/11/2018
Nicholas Edward John West CTO	Chief Tech/Sci/R&D Officer	58	-

Director	Title	Age	Since
David Fortunati BRD	Director/Board Member	-	31/05/2024
Vincent Sommella BRD	Director/Board Member	-	31/05/2024
Jennifer Kozak BRD	Director/Board Member	-	31/05/2024

Date	Insider	Type	Main position	Quantity	% Market Cap.
31/05/24	Douglas Godshall	Issuer sale	Chief Executive Officer	629,205	1.6781%
31/05/24	Trinh Phung	Issuer sale	Chief Financial Officer	50,387	0.1344%
31/05/24	Frank Watkins	Issuer sale	Director	106,226	0.2833%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SHOCKWAVE MEDICAL	-0.01%	+0.01%	+0.01%	+25.03%	12.57B
PENUMBRA, INC.	-0.40%	+0.07%	+38.17%	+5.28%	12.52B
GETINGE AB	+10.14%	+11.94%	+15.79%	+20.81%	6.57B
ASAHI INTECC CO., LTD.	+2.91%	-0.11%	+55.48%	+28.89%	5.83B
MINIMED GROUP, INC.	+6.61%	+10.73%	-	-	4.75B
APT MEDICAL INC.	-2.77%	-0.34%	-29.59%	+18.12%	4.25B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	-2.01%	+4.84%	-22.35%	-22.74%	4.02B
NOVOCURE LIMITED	-3.05%	-2.33%	-0.62%	-59.27%	1.84B
IMPLANTICA AG	-3.31%	-6.97%	-4.51%	+254.50%	1.8B
NAKANISHI INC.	0.00%	+0.66%	+59.44%	-3.17%	1.56B
Average	+0.81%	+1.62%	+12.42%	+29.72%	5.57B
Weighted average by Cap.	+1.41%	+2.20%	+15.17%	+19.95%

3 years	157	334.9
5 years	113.36	334.9
10 years	22.01	334.9

	2025 *	2026 *
Net sales	-	-
Net income	-	-
Net Debt	-	-